JSM2026
Back to all people

Gina D'Angelo

AstraZeneca
5 appearances in the program

Sessions & presentations

Integrating biomarker discovery and dose-optimization to drive drug development success
Topic-Contributed Paper Session · Tue, Aug 4 , 4:00 PM
Organizer
Current methodology advances and practice in oncology dose optimization studies
Presentation: Dose optimization strategies and practice based on the industry survey and dose optimization whitepaper from a KOL panel discussion
Topic-Contributed Paper Session · Wed, Aug 5 , 8:30 AM
Co-Author
Current methodology advances and practice in oncology dose optimization studies
Presentation: Utility-Based Dose Optimization Approaches for Multiple-Dose Randomized Trial Designs Accounting for Multiple Endpoints
Topic-Contributed Paper Session · Wed, Aug 5 , 8:30 AM
Speaker
Current methodology advances and practice in oncology dose optimization studies
Presentation: Utility-Based Dose Optimization Approaches for Multiple-Dose Randomized Trial Designs Accounting for Multiple Endpoints
Topic-Contributed Paper Session · Wed, Aug 5 , 8:30 AM
Co-Author